FDA Reopens Comment Period for Guidance on IND Applications for Cosmetics and Foods Research

Summary

The US Food and Drug Administration (FDA) is reopening the comment period for a guidance document that clarifies when human research studies involving cosmetics and foods can be conducted without an Investigational New Drug (IND) application, previously published in 2013.